Matthias Tschöp
Matthias Tschöp is the head of the Health Research area at the Helmholtz Association in Germany and is known for his groundbreaking work in obesity and metabolic diseases. He played a crucial role in the development of advanced treatments like Tirzepatide, which continue to reshape the landscape of obesity therapy.
Not in the pool (under ¢1).
Recent news mentions
Matthias Tschöp is the President of Ludwig Maximilian University of Munich.
Faßmann: "Einschnitte in US-Wissenschaft schlimmer als befürchtet" - Forschung Spezial
Austria· 2026-02-14
Matthias Tschöp is the president of Ludwig-Maximilians-Universität in Munich and one of the developers of the weight loss injection.
Mit der Abnehmspritze Krankheiten vorbeugen
Switzerland· 2025-11-15
Matthias Tschöp has succeeded Bernd Huber as the president of LMU.
Semesterstart an Münchner Unis: Wie wirkt sich der fehlende Abijahrgang aus? - München
Germany· 2025-10-13
Matthias Tschöp will take over the presidency of LMU from Bernd Huber after 23 years.
LMU München: Was folgt auf das „System Huber“? - die Pläne des neuen Uni-Präsidenten - MünchenGermany· 2025-08-21
Matthias Tschöp co-authored the article addressing the dangers to scientific freedom.
Die Bedrohung der Wissenschaftsfreiheit gefährdet die Demokratie - WissenGermany· 2025-06-12
Matthias Tschöp is the scientific director of the Helmholtz Center Munich and the designated president of Ludwig Maximilian University of Munich.
USA: Kennedy will Publikationen in medizinischen Fachzeitschriften untersagen - WissenGermany· 2025-05-29
Matthias Tschöp is the new president of Ludwig Maximilians University in Munich, returning to the institution where he studied.
Neuer LMU-Präsident Tschöp will Wissenschaftsfreiheit und Autonomie verteidigen - MünchenGermany· 2025-02-28
Matthias Tschöp is a renowned scientist known for his work in diabetes and obesity research and has been appointed as the new president of Ludwig-Maximilians-Universität.
München: Matthias Tschöp wird neuer Präsident der Ludwig-Maximilians-Universität - MünchenGermany· 2025-02-20
Matthias Tschöp is the head of the health research area at the Helmholtz Association and was significantly involved in the development of Wegovy's successor.
Ozempic und Wegovy - hilfreich auch gegen Krebs, Herzinfarkt und Süchte?Switzerland· 2025-02-10
